The College* accepts support from pharmaceutical and medical device/equipment companies to enable the College to carry out its mission to advocate for improved quality cardiovascular (CV) care and to promote science, as well as CV workforce development, diversity, medical education and lifelong learning. The College solicits and uses such commercial support in a manner consistent with the following policies:
- Principles for Relationships with Industry
- Code of Ethics
- Non-Certified Content Policy
- Clinical and Scientific Content Disclaimer
- Partnership Policies for the CardioSmart National Health Initiative
- Disclosure of relationship between the American College of Cardiology and Health Outcomes Sciences
In addition, the College adheres to external rules and guidance related to commercial support including: Internal Revenue Service regulations governing organizations classified as federally tax exempt under sections 501(c)(3) and 501(c)(6) of the Internal Revenue Code; Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support; Advanced Medical Technology Association (AdvaMed) Code of Ethics for Interactions with Health Care Professionals; American Medical Association Opinion 8.061—Gifts to Physicians from Industry; Office of Inspector General (OIG)—Compliance Program Guidance for Pharmaceutical Manufacturers; and Pharmaceutical Research and Manufacturers of America (PhRMA)—Code on Interaction with Healthcare Professionals.
* The term College refers to both the American College of Cardiology Foundation ("ACCF"), a nonprofit 501(c)(3) organization, and the American College of Cardiology ("ACC"), a nonprofit 501(c)(6) professional medical society. All educational grants, charitable contributions and awards support ACCF. Both ACCF and ACC receive support from sponsorship, promotional grants and advertising. ACC receives all of the support from exhibits and exposition space sales.